...
首页> 外文期刊>Radiotherapy and oncology: Journal of the European Society for Therapeutic Radiology and Oncology >Feasibility of using intensity-modulated radiotherapy to improve lung sparing in treatment planning for distal esophageal cancer.
【24h】

Feasibility of using intensity-modulated radiotherapy to improve lung sparing in treatment planning for distal esophageal cancer.

机译:在远端食管癌的治疗计划中使用强度调节放疗改善肺保留的可行性。

获取原文
获取原文并翻译 | 示例
           

摘要

BACKGROUND AND PURPOSE: To evaluate the feasibility whether intensity-modulated radiotherapy (IMRT) can be used to reduce doses to normal lung than three-dimensional conformal radiotherapy (3 DCRT) in treating distal esophageal malignancies. PATIENTS AND METHODS: Ten patient cases with cancer of the distal esophagus were selected for a retrospective treatment-planning study. IMRT plans using four, seven, and nine beams (4B, 7B, and 9B) were developed for each patient and compared with the 3 DCRT plan used clinically. IMRT and 3 DCRT plans were evaluated with respect to PTV coverage and dose-volumes to irradiated normal structures, with statistical comparison made between the two types of plans using the Wilcoxon matched-pair signed-rank test. RESULTS: IMRT plans (4B, 7B, 9B) reduced total lung volume treated above 10 Gy (V(10)), 20 Gy (V(20)), mean lung dose (MLD), biological effective volume (V(eff)), and lung integral dose (P<0.05). The median absolute improvement with IMRT over 3DCRT was approximately 10% for V(10), 5% for V(20), and 2.5 Gy for MLD. IMRT improved the PTV heterogeneity (P<0.05), yet conformity was better with 7B-9B IMRT plans. No clinically meaningful differences were observed with respect to the irradiated volumes of spinal cord, heart, liver, or total body integral doses. CONCLUSIONS: Dose-volume of exposed normal lung can be reduced with IMRT, though clinical investigations are warranted to assess IMRT treatment outcome of esophagus cancers.
机译:背景与目的:为了评估是否可以使用强度调节放疗(IMRT)来减少对正常肺部的剂量,而不是三维适形放疗(3 DCRT)在治疗远端食管恶性肿瘤。患者与方法:选择十例患有远端食道癌的患者进行回顾性治疗计划研究。针对每位患者制定了使用四个,七个和九个光束(4B,7B和9B)的IMRT计划,并将其与临床使用的3个DCRT计划进行了比较。评估了IMRT和3个DCRT计划的PTV覆盖率和照射到正常结构的剂量,并使用Wilcoxon配对配对秩和检验对两种类型的计划进行了统计比较。结果:IMRT计划(4B,7B,9B)减少了10 Gy(V(10)),20 Gy(V(20)),平均肺部剂量(MLD),生物有效量(V(eff) )和肺积分剂量(P <0.05)。 IMRT超过3DCRT的中值绝对改善率对于V(10)约为10%,对于V(20)为5%,对于MLD为2.5 Gy。 IMRT改善了PTV的异质性(P <0.05),但与7B-9B IMRT计划的一致性更好。对于脊髓,心脏,肝脏或全身总剂量的照射量,没有观察到临床意义上的差异。结论:IMRT可以减少裸露的正常肺的剂量,尽管需要进行临床研究以评估食管癌的IMRT治疗结果。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号